Cargando…
Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
Background. Joint symptoms (JSs) are problematic adverse drug reactions (ADRs) of aromatase inhibitors (AIs). Involvement of decreased serum estradiol (SE) has been suggested. Patients and Methods. 104 postmenopausal breast cancer patients administered an AI were prospectively investigated regarding...
Autores principales: | Honda, Junko, Kanematsu, Miyuki, Nakagawa, Misako, Takahashi, Masako, Nagao, Taeko, Tangoku, Akira, Sasa, Mitsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263690/ https://www.ncbi.nlm.nih.gov/pubmed/22312534 http://dx.doi.org/10.1155/2011/951260 |
Ejemplares similares
-
The time since last menstrual period is important as a clinical predictor for non-steroidal aromatase inhibitor-related arthralgia
por: Kanematsu, Miyuki, et al.
Publicado: (2011) -
Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
por: Nagao, Taeko, et al.
Publicado: (2009) -
A case of matrix-producing carcinoma of the breast
por: Hirose, Toshiyuki, et al.
Publicado: (2008) -
Bilateral male breast cancer with male potential hypogonadism
por: Hirose, Yukiko, et al.
Publicado: (2007) -
Letrozole increases preantral follicle growth and decreases estradiol production without impairing follicle survival
por: Kasuga-Yamashita, Fukiko, et al.
Publicado: (2022)